Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

The inclusion of real world evidence in clinical development planning
ConclusionThe use of RWE resulted in a reduced sample size of the pivotal phase III studies, which led to substantial time savings compared to the approach of sample size calculations without RWE. (Source: Trials)
Source: Trials - August 29, 2018 Category: Research Source Type: clinical trials

Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis
Condition:   Relapsing Remitting Multiple Sclerosis Interventions:   Drug: Fingolimod;   Drug: Dimethyl Fumarate Sponsors:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Patient-Centered Outcomes Research Institute;   Universita degli Studi di Genova Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials